发明名称 |
Antimalarial drug which contains 5-aminolevulinic acid or derivative thereof as active ingredient |
摘要 |
Provided is an antimalarial drug which is useful for prevention and treatment of infectious diseases caused by malaria parasites. A preventive and/or therapeutic agent for malaria, which contains, as an active ingredient, 5-aminolevulinic acid (ALA), a derivative thereof, or a pharmacologically acceptable salt thereof, is used. |
申请公布号 |
US9089530(B2) |
申请公布日期 |
2015.07.28 |
申请号 |
US201113698090 |
申请日期 |
2011.05.18 |
申请人 |
SBI Pharmaceuticals Co., Ltd.;The University of Tokyo |
发明人 |
Tanaka Tohru;Kawata Satofumi;Kohda Takeo;Nakajima Motowo;Kita Kiyoshi |
分类号 |
A61K31/197;A61K33/26;A61K45/06;A61K31/221;A61K33/06;A61K33/30;A61K9/48 |
主分类号 |
A61K31/197 |
代理机构 |
Chalker Flores, LLP |
代理人 |
Singleton Chainey P.;Flores Edwin S.;Chalker Flores, LLP |
主权项 |
1. A method for treating or preventing malaria in a subject without performing light irradiation comprising the steps of:
identifying a subject suspected of having malaria; and administering a therapeutically effective amount of a compound represented by the following formula (I) or a pharmacologically acceptable salt thereof, wherein R1 represents a hydrogen atom or an acyl group, and R2 represents a hydrogen atom, a linear or branched alkyl group, a cycloalkyl group, an aralkyl group, or an aryl group; in combination with one or more kinds of metal-containing compounds, wherein the metal portion of the metal-containing compound is iron, magnesium, or zinc. |
地址 |
Tokyo JP |